X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
oncology (42) 42
female (35) 35
index medicus (34) 34
standard-dose chemotherapy (30) 30
chemotherapy (29) 29
middle aged (24) 24
cancer (23) 23
adult (21) 21
male (19) 19
standard-dose doxorubicin (19) 19
aged (17) 17
breast cancer (14) 14
treatment outcome (14) 14
adjuvant chemotherapy (13) 13
drug therapy (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
breast neoplasms - drug therapy (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
european-organization (11) 11
antineoplastic agents - therapeutic use (10) 10
cognition disorders - chemically induced (10) 10
cognitive function (10) 10
analysis (9) 9
antineoplastic agents - adverse effects (9) 9
doxorubicin - administration & dosage (9) 9
doxorubicin - adverse effects (9) 9
hematology, oncology and palliative medicine (9) 9
research (9) 9
sarcoma - drug therapy (9) 9
soft tissue sarcoma (9) 9
care and treatment (8) 8
doxorubicin (8) 8
therapy (8) 8
cognition (7) 7
doxorubicin - therapeutic use (7) 7
metastasis (7) 7
sarcoma (7) 7
survivors (7) 7
animals (6) 6
article (6) 6
breast neoplasms - psychology (6) 6
cognition disorders - etiology (6) 6
impairment (6) 6
neoplasm metastasis (6) 6
neoplasms - drug therapy (6) 6
oncology, experimental (6) 6
plus ifosfamide (6) 6
prognosis (6) 6
quality-of-life (6) 6
randomized phase-ii (6) 6
receiving adjuvant chemotherapy (6) 6
trial (6) 6
adolescent (5) 5
anthracyclines (5) 5
breast-cancer (5) 5
chemotherapy, adjuvant (5) 5
cognition - drug effects (5) 5
colony-stimulating factor (5) 5
drug administration schedule (5) 5
gynecologic-oncology-group (5) 5
medicine & public health (5) 5
memory (5) 5
pharmacology & pharmacy (5) 5
randomized controlled trials as topic (5) 5
survival (5) 5
women (5) 5
1st-line treatment (4) 4
adriamycin (4) 4
aged, 80 and over (4) 4
breast-cancer patients (4) 4
breast-cancer survivors (4) 4
cell lung-cancer (4) 4
central-nervous-system (4) 4
clinical trials (4) 4
disease-free survival (4) 4
neoplasm staging (4) 4
neoplasms - psychology (4) 4
neurosciences (4) 4
patients (4) 4
prospective studies (4) 4
quality of life (4) 4
sarcoma - mortality (4) 4
sarcoma - pathology (4) 4
soft-tissue sarcomas (4) 4
solid tumors (4) 4
young adult (4) 4
abridged index medicus (3) 3
anemia (3) 3
antineoplastic agents - administration & dosage (3) 3
behavioral sciences (3) 3
brain (3) 3
cancer patients (3) 3
chemo-brain (3) 3
chemotherapy, adjuvant - adverse effects (3) 3
clinical trials as topic (3) 3
cognition disorders - psychology (3) 3
combination (3) 3
combined modality therapy (3) 3
development and progression (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2016, Volume 34, Issue 19, pp. 2294 - 2302
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 48, Issue 4, pp. 547 - 563
Journal Article
Journal Article
Oncology, ISSN 0030-2414, 06/2011, Volume 80, Issue 1-2, pp. 50 - 56
Purpose: The purpose of this study was to determine the dose-limiting toxicities (DLT), maximum tolerated dose (MTD), safety, pharmacokinetics and preliminary... 
Clinical Study | Soft tissue sarcoma | Hypoxia-activated prodrug | Phase I clinical trial | TH-302 | STANDARD-DOSE DOXORUBICIN | SOLID TUMORS | TIRAPAZAMINE | CELL LUNG-CANCER | PLUS IFOSFAMIDE | ONCOLOGY | EUROPEAN-ORGANIZATION | EXPRESSION | III TRIAL | Doxorubicin - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Nitroimidazoles - adverse effects | Nitroimidazoles - therapeutic use | Phosphoramide Mustards - pharmacokinetics | Phosphoramide Mustards - therapeutic use | Doxorubicin - analogs & derivatives | Phosphoramide Mustards - adverse effects | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Doxorubicin - metabolism | Neutropenia - chemically induced | Nitroimidazoles - pharmacokinetics | Drug Eruptions | Abscess - etiology | Anemia - chemically induced | Treatment Outcome | Granulocyte Colony-Stimulating Factor - therapeutic use | Sarcoma - drug therapy | Doxorubicin - pharmacokinetics | Neutropenia - drug therapy | Cellulitis - chemically induced | Disease-Free Survival | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sarcoma - surgery | Stomatitis - chemically induced | Aged | Doxorubicin - adverse effects | Lymphopenia - chemically induced | Drug therapy | Pharmacology | Cancer | Index Medicus
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2019, Volume 19, Issue 1, pp. 56 - 9
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 07/2017, Volume 10, Issue 7, pp. 699 - 705
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 58, pp. 62 - 72
Journal Article